Finished
Improvement of Pain Following Robotic Sacrocolpopexy and Rectocele Repair for Pelvic Organ Prolapse
NCT02449915 · TriHealth Inc. · Updated 8 Dec 2017
- What is being tested
- Bupivacaine; Placebo
- For
- Pelvic Organ Prolapse
- Kind of study
- Tests a treatment or device on volunteers. Phase 4.
- Who can join
- Ages 18 years and older. About 70 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started March 2015, ends Aug 2016. Registered 20 May 2015.
- Results
- Posted on the registry on 8 Dec 2017.
In the researchers' words
To determine if the injection of liposomal bupivacaine to laparoscopic port sites and rectocele repair incisions at the completion of a robotic sacrocolpopexy with concomitant rectocele repair will result in decreased postoperative pain compared to injection of placebo.
Sites
- Cincinnati Urogynecology AssociatesCincinnati, Ohio, United States